BioSpace News Archive

ETHICON LAUNCHES COMPREHENSIVE SOLUTION FOR BARIATRIC REVISION SURGERY

Portfolio of Products, Education and Training to Help Surgeons Handle Challenging Reoperations

September 28, 2018
·
7 min read
Business

MorphoSys Announces its Licensee Janssen has Initiated a Phase 3 Trial (PROTOSTAR) to Evaluate Guselkumab in Pediatric Psoriasis Patients

MorphoSys AG (FSE: MOR; Prime Standard Segment, MDAX & TecDAX; NASDAQ: MOR) announced today that its licensee Janssen Research & Development, LLC, has initiated a phase 3 clinical trial of guselkumab in pediatric patients suffering from chronic plaque psoriasis.

September 28, 2018
·
4 min read
Biotech Bay

Amaranth Presented MAGNITUDE (98 micron) Nine-Month Follow-up Clinical Results and Introduced DEFIANCE (85 micron) BRS Development Plan at TCT

Amaranth Medical provided an update on the company’s sirolimus-eluting bioresorbable scaffold (BRS) products at the annual Transcatheter Cardiovascular Therapeutics (TCT) meeting during the following sessions

September 28, 2018
·
4 min read
Job Trends

Myriad Announces Publication of Variant Reclassification Study in the Journal of the American Medical Association

Myriad Genetics, Inc. today announced that results from a landmark study of variant classifications following hereditary cancer genetic testing were published in the Journal of the American Medical Association (JAMA).

September 28, 2018
·
7 min read
BioMidwest

Destaco Introduces Tolerance Compensation Clamp Series

Innovative clamping solution streamlines demanding welding and assembly applications in the automotive, aircraft and consumer goods industries

September 28, 2018
·
3 min read
Genetown

KSQ Gains $80 Million Series C Financing for CRISPRomics Development

Just this morning, KSQ Therapeutics disclosed that they’ve obtained an $80 million Series C financing that will be put towards the development of oncology drug candidates via CRISPRomics™, a drug discovery engine that creates insights specific to individual human genes on an industrial scale.

September 28, 2018
·
3 min read
·
Elizabeth Glasure
Business

Viracta Announces Scientific Advisory Board

Viracta Therapeutics, Inc. announced the formation of its inaugural Scientific Advisory Board.

September 28, 2018
·
3 min read
Pharm Country

Loxo Oncology Announces LOXO-292 Durability Update in Patients with RET Fusion-Positive Non-Small Cell Lung Cancer from LIBRETTO-001 at the IASLC 19th World Conference on Lung Cancer

25/26 (96%) Responding Patients Remain on Therapy, With Median Follow-Up of 9.5 Months

September 28, 2018
·
7 min read
Deals

Fusion Antibodies plc (“Fusion” or the “Company”) Director/PDMR Shareholding

Fusion Antibodies plc announces that it has been informed by Alan Mawson, a Non-Executive Director of the Company, that on 24 September 2018 he purchased 8,500 ordinary shares in the Company (“Ordinary Shares”) at a price of 67 pence per Ordinary Share via his personal pension scheme.

September 28, 2018
·
2 min read
Pharm Country

New Cell Assay Service by Reaction Biology and Promega Will Allow More Researchers to Better Prioritize Compounds Earlier

A new cell based profiling service for drug discovery announced by Reaction Biology Corporation (RBC), a premier provider of drug discovery services, and Promega Corporation, a worldwide leader in the supply of life science products, will allow more researchers to better prioritize compounds earlier.

September 28, 2018
·
2 min read